Clinical trial
A Study in Subjects With Perennial Allergic Rhinitis
NCT00210015 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00210015 |
|---|---|
| Title | A Study in Subjects With Perennial Allergic Rhinitis |
| Official title | A Multi-Center, Randomized, Parallel-Group, Double-Blind, Efficacy and Safety Study of INS37217 Nasal Spray Versus Placebo in Subjects With Perennial Allergic Rhinitis |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Perennial Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | INS37217 Nasal Spray |
| Enrollment | 630 |
| Start date | Dec 1, 2002 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 25, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: